Dermata Therapeutics, Inc. - Common Stock (DRMA)
2.7300
-0.2800 (-9.30%)
NASDAQ · Last Trade: Dec 4th, 11:28 AM EST
Via Benzinga · November 20, 2025
Via Benzinga · November 19, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via Chartmill · October 8, 2025
Via Benzinga · October 7, 2025
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via Chartmill · October 7, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · October 7, 2025
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · October 7, 2025
Via Benzinga · October 7, 2025
Via Benzinga · October 7, 2025
Via Benzinga · October 6, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · October 6, 2025
Via Benzinga · September 3, 2025
Via Benzinga · July 7, 2025
Via Benzinga · March 28, 2025
Via Benzinga · March 28, 2025
U.S. stock futures fell on Friday after two consecutive days of decline on Wednesday and Thursday. Futures of benchmark indices were lower.
Via Benzinga · March 28, 2025
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · March 27, 2025
Via Benzinga · March 27, 2025
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · March 27, 2025
Dermata's Xyngari showed significant acne improvement in Phase 3 results. A second pivotal trial is set for the second half of 2025.
Via Benzinga · March 27, 2025
Via Benzinga · March 27, 2025

Via Benzinga · September 17, 2024


